HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Palaniappan, R. Articles by Lillard, J. W. Search for Related Content PubMed PubMed Citation Articles by Palaniappan, R. Articles by Lillard, J. W., Jr.

CCL5 Modulates Pneumococcal Immunity and Carriage¹

Ravichandran Palaniappan^*,, Shailesh Singh, Udai P. Singh, Rajesh Singh, Edwin W. Ades, David E. Briles, Susan K. Hollingshead, Walter Royal, III, Jacquelyn S. Sampson, Jonathan K. Stiles, Dennis D. Taub^¶ and James W. Lillard, Jr.^2,,

^* Mercer University, Atlanta GA 30341; Morehouse School of Medicine, Atlanta, GA 30310; Centers for Disease Control and Prevention, Atlanta, GA 30333; University of Alabama at Birmingham, Birmingham, AL 35294; and ^¶ National Institute on Aging, National Institutes of Health, Baltimore, MD 21224

Understanding the requirements for protection against pneumococcal carriage and pneumonia will greatly benefit efforts in controlling these diseases. Recently, it has been shown that genetic polymorphisms can result in diminished expression of CCL5, which results in increased susceptibility to and progression of infectious diseases. We show that CCL5, together with Th cytokine mRNA expression, is temporally up-regulated during pneumococcal carriage. To determine the contribution of CCL5 to pneumococcal surface antigen A-specific humoral and cellular pneumococcal immunity, mice were treated with anti-CCL5 or control Abs before and during Streptococcus pneumoniae strain EF3030-challenge for the initiation of carriage. CCL5 blockade resulted in a decrease of CD4⁺ and CD8⁺ T cells as well as CD11b⁺ cells in the spleen, cervical lymph node, lung, and nasopharyngeal associated lymphoid tissue during the recognition phase of the pneumococcal adaptive immune response. CCL5 blockade significantly reduced the Ag-specific IgG2a and IgG1 Abs in serum and IgA Ab levels in nasal washes. These decreases also corresponded to reductions in Ag-specific T cell (mucosal and systemic) responses. CCL5 inhibition resulted in decreasing the quantity of IL-4- and IFN--secreting CD4⁺ T cells and increasing the number of Ag-specific IL-10-producing CD4⁺ T cells; these changes combined also corresponded with the transition from pneumococcal carriage to lethal pneumonia. These data suggest that CCL5 is an essential factor for the induction and maintenance of protective pneumococcal immunity.

This article has been cited by other articles:

				L. K. Mahdi, A. D. Ogunniyi, K. S. LeMessurier, and J. C. Paton Pneumococcal Virulence Gene Expression and Host Cytokine Profiles during Pathogenesis of Invasive Disease Infect. Immun., February 1, 2008; 76(2): 646 - 657. [Abstract] [Full Text] [PDF]